Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uveal Melanoma × Epilim × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 1

Interventions

tebentafusp 2 pembrolizumab 2 Cyclophosphamide 2 ulixertinib 1 trametinib 1 omipalisib 1 fludarabine phosphate 1 Vorinostat 1 Valproic Acid 1 Sunitinib 1 Specimen Handling 1 Radiosurgery 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 LY2940680 1 Ipilimumab 1 Interleukin-13 1 Imatinib Mesylate 1 GSK2141795 1 Fluorodeoxyglucose F18 1 Epilim 1 Dacarbazine 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02068586 2026-03-16

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

Thomas Jefferson University

Phase 2 Active not recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡